| Adipose tissue immunomodulation: a novel therapeutic approach in cardiovascular and metabolic diseases I AlZaim, SH Hammoud, H Al-Koussa, A Ghazi, AH Eid, AF El-Yazbi Frontiers in cardiovascular medicine 7, 602088, 2020 | 77 | 2020 |
| Perirenal adipose tissue inflammation: novel insights linking metabolic dysfunction to renal diseases SH Hammoud, I AlZaim, Y Al-Dhaheri, AH Eid, AF El-Yazbi Frontiers in Endocrinology 12, 707126, 2021 | 47 | 2021 |
| The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity I AlZaim, LPMH de Rooij, BN Sheikh, E Börgeson, J Kalucka Nature Reviews Endocrinology 19 (12), 691-707, 2023 | 45 | 2023 |
| Pathophysiology of coagulation and emerging roles for extracellular vesicles in coagulation cascades and disorders H Al-Koussa, I AlZaim, ME El-Sabban Journal of clinical medicine 11 (16), 4932, 2022 | 33 | 2022 |
| Peri-renal adipose inflammation contributes to renal dysfunction in a non-obese prediabetic rat model: Role of anti-diabetic drugs SH Hammoud, I AlZaim, N Mougharbil, S Koubar, AH Eid, AA Eid, ... Biochemical Pharmacology 186, 114491, 2021 | 33 | 2021 |
| Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and … HH Shaaban, I Alzaim, A El-Mallah, RG Aly, AF El-Yazbi, A Wahid Life Sciences 308, 120956, 2022 | 26 | 2022 |
| Early metabolic impairment as a contributor to neurodegenerative disease: Mechanisms and potential pharmacological intervention W Fakih, R Zeitoun, I AlZaim, AH Eid, F Kobeissy, KS Abd‐Elrahman, ... Obesity 30 (5), 982-993, 2022 | 25 | 2022 |
| Modulatory effect of intermittent fasting on adipose tissue inflammation: amelioration of cardiovascular dysfunction in early metabolic impairment HS Dwaib, I AlZaim, AH Eid, O Obeid, AF El-Yazbi Frontiers in Pharmacology 12, 626313, 2021 | 25 | 2021 |
| The emerging role of COX-2, 15-LOX and PPARγ in metabolic diseases and cancer: an introduction to novel multi-target directed ligands (MTDLs) RA Alaaeddine, PA Elzahhar, I AlZaim, W Abou-Kheir, ASF Belal, ... Current Medicinal Chemistry 28 (11), 2260-2300, 2021 | 25 | 2021 |
| The pleiotropic effects of antithrombotic drugs in the metabolic–cardiovascular–neurodegenerative disease continuum: Impact beyond reduced clotting RA Alaaeddine, I AlZaim, SH Hammoud, A Arakji, AH Eid, ... Clinical Science 135 (8), 1015-1051, 2021 | 18 | 2021 |
| Phosphorus supplementation mitigates perivascular adipose inflammation–induced cardiovascular consequences in early metabolic impairment HS Dwaib, G Ajouz, I AlZaim, R Rafeh, A Mroueh, N Mougharbil, ME Ragi, ... Journal of the American Heart Association 10 (24), e023227, 2021 | 17 | 2021 |
| Thromboinflammatory processes at the nexus of metabolic dysfunction and prostate cancer: the emerging role of periprostatic adipose tissue I AlZaim, A Al-Saidi, SH Hammoud, N Darwiche, Y Al-Dhaheri, AH Eid, ... Cancers 14 (7), 1679, 2022 | 13 | 2022 |
| Transforming iodoquinol into broad spectrum anti-tumor leads: Repurposing to modulate redox homeostasis I Chaaban, H Hafez, I AlZaim, C Tannous, H Ragab, A Hazzaa, S Ketat, ... Bioorganic Chemistry 113, 105035, 2021 | 13 | 2021 |
| Knowledge and beliefs of cancer risk factors and early cancer symptoms in Lebanon: A cross-sectional survey among adults in the community G Hatem, D Ghanem, E Kellen, I AlZaim, M Goossens Cancer Control 28, 10732748211053149, 2021 | 11 | 2021 |
| Adipose tissue mitochondrial dysfunction and cardiometabolic diseases: On the search for novel molecular targets I AlZaim, AH Eid, KS Abd-Elrahman, AF El-Yazbi Biochemical Pharmacology 206, 115337, 2022 | 8 | 2022 |
| Depot-specific adipose tissue modulation by SGLT2 inhibitors and GLP1 agonists mediates their cardioprotective effects in metabolic disease NMZ Bakkar, I AlZaim, AF El-Yazbi Clinical Science 136 (22), 1631-1651, 2022 | 8 | 2022 |
| Adipose tissue endothelial cells: insights into their heterogeneity and functional diversity J Festa, I AlZaim, J Kalucka Current Opinion in Genetics & Development 81, 102055, 2023 | 7 | 2023 |
| Sex differences in cardiovascular impact of early metabolic impairment: interplay between dysbiosis and adipose inflammation HS Dwaib, I AlZaim, G Ajouz, AH Eid, A El-Yazbi Molecular Pharmacology 102 (1), 60-79, 2022 | 4 | 2022 |
| Batokine neuregulin 4 promotes atherosclerotic resolution I AlZaim, J Kalucka Nature Metabolism 4 (11), 1440-1441, 2022 | 3 | 2022 |
| Depot-biased ROS: a middleman in adipose-driven cardiovascular disease NMZ Bakkar, ST Osman, I Alzaim, AF El-Yazbi Oxidative Stress in Cardiovascular-Metabolic Diseases, 97-118, 2024 | 2 | 2024 |
Ahmed El-Yazbi, BPharm, PhD, BCPS,...Faculty of Pharmacy, Alexandria University and Faculty of Pharmacy, Alamein International UniversityVerified email at aiu.edu.eg
